Clincosm LogoSign in Get a demo

small cell lung carcinoma

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Neuroendocrine Neoplasms
  • BI 764532
  • (no location specified)
May 22, 2023

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Small Cell Lung Carcinoma Trial in Worldwide (Pembrolizumab/Vibostolimab Co-Formulation, Saline , Etoposide)

Recruiting
  • Small Cell Lung Carcinoma
  • Pembrolizumab/Vibostolimab Co-Formulation
  • +5 more
  • Los Angeles, California
  • +122 more
Jan 27, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Small Cell Lung Carcinoma Trial in France (Durvalumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Aix-en-Provence, France
  • +35 more
Jan 16, 2023

EvaluatioN of durvALumab Utilization and Effectiveness for First

Recruiting
  • Small Cell Lung Carcinoma
  • Angers, France
  • +24 more
Jan 12, 2023

Small Cell Lung Carcinoma Trial in Worldwide (coformulation pembrolizumab/quavonlimab, lenvatinib, MK-4830)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • coformulation pembrolizumab/quavonlimab
  • +3 more
  • Gilbert, Arizona
  • +46 more
Jan 2, 2023

Small Cell Lung Carcinoma Trial in Italy (Atezolizumab, Carboplatin, Etoposide)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Rionero In Vulture (PZ), Basilicata, Italy
  • +24 more
Dec 12, 2022

Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)

Recruiting
  • Small Cell Lung Carcinoma
  • AMG 757
  • +2 more
  • Duarte, California
  • +34 more
Dec 6, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Small Cell Lung Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +3 more
  • Fort Myers, Florida
  • +113 more
Nov 30, 2022

Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • iC9.GD2.CAR.IL-15 T Infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 16, 2022

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

Recruiting
  • Lung Cancer
  • +5 more
  • Stereotactic Radiosurgery
  • Cerebrospinal fluid collection
  • Basking Ridge, New Jersey
  • +6 more
Nov 11, 2022

Small Cell Lung Carcinoma Trial in Orlando, San Antonio (JDQ443)

Suspended
  • Small Cell Lung Carcinoma
  • Orlando, Florida
  • +1 more
Oct 17, 2022

Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • +7 more
  • Regorafenib in combination with Tislelizumab
  • (no location specified)
Oct 12, 2022

Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,

Completed
Has Results
  • Small Cell Lung Carcinoma
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Sep 6, 2022

Small Cell Lung Carcinoma Trial in Denmark, Norway, Sweden (45 Gy in 30 fractions, 60 Gy in 40 fractions)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • 45 Gy in 30 fractions
  • 60 Gy in 40 fractions
  • København, Denmark
  • +21 more
Sep 16, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in United States (Olaparib Pill 50 mg, Olaparib Pill 100 mg, Olaparib

Active, not recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Olaparib Pill 50 mg
  • +6 more
  • Miami, Florida
  • +8 more
Sep 14, 2022

Atezolizumab in Ministry of Food and Drug Safety-Approved

Completed
  • Urothelial Carcinoma
  • +4 more
  • Busan, Korea, Republic of
  • +55 more
Aug 23, 2022

Small Cell Lung Carcinoma Trial in China (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Beijing, China
  • +15 more
Aug 15, 2022

Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Barcelona, Spain
  • +4 more
Aug 12, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)

Not yet recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Mycophenolate Mofetil
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
May 17, 2022